tirzepatide to semaglutide conversion chart Switching from dose Switching from Semaglutide to Tirzapetide

Recent FDA Guidance on Compounded GLP-1s: In October 2023, the FDA issued warnings about compounded GLP-1 medications, specifically cautioning patients to ensure theyre receiving semaglutide (the actual FDA-approved ingredient) rather than semaglutide salts, which have different properties

Mounjaro holds 79% of the GLP-1 medication market in the UK, compared to competitor Wegovy with 20%

Scale going up despite being in a deficit

Tracking protects against underreporting or overreporting that can occur due to temporary feelings

Even in detailed exchanges with customer service, we were never able to locate the specifics of this policy on the found website